| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 12/31/20 | 8-K | Current report filing |
|
33 | |
| 12/31/20 | 8-K/A | Current report filing |
|
10 | |
| 12/22/20 | 8-K | Current report filing |
|
5 | |
| 12/10/20 | 8-K | Current report filing |
|
5 | |
| 12/02/20 | 8-K | Current report filing |
|
6 | |
| 11/23/20 | UPLOAD | SEC-generated letter |
|
1 | |
| 11/20/20 | S-1 | General form of registration statement for all companies including face-amount certificate companies |
|
   |
255 |
| 11/19/20 | 8-K | Current report filing |
|
6 | |
| 11/13/20 | DRS | Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy |
|
137 | |
| 11/10/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
Lexaria Bioscience Corp.
Lexaria Bioscience Corp.